| 23707/34351 | US=67 / Biol/Mol Champaneria MC, Modlin IM, Latich I, Bornschein J, Drozdov I, Kidd M. Somatostatin analogue therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 585-637. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. TERAPIA ANALOGA DA SOMATOSTATINA; ACROMEGALIA; CARCINOIDE; SINDROME CARCINOIDE; HORMONIO DE CRESCIMENTO; LUTECIO; OCTREOTIDE; NEUROENDOCRINO; PROLIFERACAO; CINTILOGRAFIA; RECEPTOR DE SOMATOSTATINA; SOMATULINA; TUMOR; ITRIO |
| 23708/34351 | US=67 / Biol/Mol Dy GK, Adjei AA. Patient selection for rational development of novel anticancer agents. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 641-8. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. AGENTES ANTICANCERIGENOS; SELECAO DOS PACIENTES; TERAPIA-ALVO; BIOMARCADORES; EXPRESSAO GENICA; AMPLIFICACAO GENICA |
| 23709/34351 | US=67 / Biol/Mol Dubey S, Schiller JH. Clinical trial design with targeted agents. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 649-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. ESTUDO CLINICO; AGENTES DIRECIONADOS; ENSAIOS CLINICOS; AGENTES ALVOS |
| 23710/34351 | US=67 / Biol/Mol Kitzen JJEM, de Jonge MJA, Verweij J. How to define treatment sucess or failure if tumors do not shrink: consequences for trial design. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 657-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MARCADOR SUBSTITUTO; TECIDO SUBSTITUTO; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DA FARNESIL TRANSFERASE; SELECAO DE PACIENTE; IMAGEM; PROJETO DESCONTINUACAO RANDOMIZADO; INDICE DE MODULACAO DO CRESCIMENTO; TAXA DE PROGRESSAO; TAXA LIVRE DE PROGRESSAO |
| 23711/34351 | US=67 / Biol/Mol Shankar LK, Menkens A, Sullivan DC. Molecular imaging in oncology. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 675-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. ONCOLOGIA; IMAGEM MOLECULAR; BIOMARCADORES DE IMAGEM; BIOMARCADORES IN VIVO; TESTES DE CANCER; PROCESSO NEOPLASICO; AGENTES PET; CONTRASTE AGENTES MR; TECNOLOGIA OPTICA |
| 23712/34351 | US=67 / Biol/Mol Chen HX, Dancey JE. Combinations of molecular-targeted therapies: opportunities and challenges. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 693-705. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. |
| 23713/34351 | US=67 / Biol/Mol Tomaszewski JE, Doroshow JH. Preclinical development of molecularly targeted agents in oncology. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 707-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. ONCOLOGIA; DESENVOLVIMENTO PRE-CLINICO; AGENTES ALVO MOLECULARES; AGENTES ANTITUMORAIS; DESENVOLVIMENTO DE DROGAS; ALVOS MOLECULARES; FARMACOCINETICA; FARMACODINAMICA; TOXICOLOGIA |
| 23714/34351 | US=67 / Imagem Murphy PS, Roychowdhury D. Incorporating imaging into drug development: and industry perspective. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 1-15. ISBN 978-0-470-11880-1. CANCER DE PULMAO; IMAGEM; DESENVOLVIMENTO DE DROGAS; BIOMARCADORES; ENSAIOS CLINICOS |
| 23715/34351 | US=67 / Imagem Dziadziuszko R, Hirsch FR, Bunn Junior PA. Advances in lung cancer treatment. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 17-37. ISBN 978-0-470-11880-1. CANCER DE PULMAO; TERAPIA; CARCINOMA DE PULMAO DE NAO-PEQUENAS CELULAS; TRATAMENTO PALIATIVO; CARCINOMA DE PULMAO DE PEQUENAS CELULAS |
| 23716/34351 | US=67 / Imagem Avila RS. Quantitative imaging in CT lung cancer drug development and evaluation. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 39-51. ISBN 978-0-470-11880-1. CANCER DE PULMAO; IMAGENS QUANTITATIVAS; TOMOGRAFIA COMPUTADORIZADA; DESENVOLVIMENTO DE DROGAS |
| 23717/34351 | US=67 / Imagem Zhao B, Schwartz LH. Volumetric ct imaging for response assessment in lung cancer: a platform for translational research. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 53-66. ISBN 978-0-470-11880-1. CANCER DE PULMAO; TOMOGRAFIA COMPUTADORIZADA VOLUMETRICA; PESQUISA TRANSLACIONAL; APLICACOES INFORMATICAS |
| 23718/34351 | US=67 / Imagem Pearson J, Tarbox L, Paladini G, Wolodzko JG, Jacobs PM, Lee Z. Emerging radiological software standards and development technologies: impact on clinical translation and trials. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 67-93. ISBN 978-0-470-11880-1. PADROES RADIOLOGICOS EMERGENTES; SOFTWARE; TECNOLOGIAS DE DESENVOLVIMENTO; TRADUCAO; ENSAIOS CLINICOS |
| 23719/34351 | US=67 / Imagem Mazumdar M, Zhou XK. Statistical considerations underlying therapeutic response criteria for lung cancer: multislice ct scanners and cad algorithms for volumetric assessment. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 95-109. ISBN 978-0-470-11880-1. CANCER DE PULMAO; CONSIDERACOES ESTATISTICAS SUBJACENTES; CRITERIOS DE RESPOSTA TERAPEUTICAS; TOMOGRAFIA MULTISLICE SCANNERS; ALGORITMOS DE CAD; AVALIACAO VOLUMETRICA |
| 23720/34351 | US=67 / Imagem Baer TM, Clark CW, Karam L. Programs supporting quantitative imaging in biomedicine at the national institute of standards and technology. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 111-22. ISBN 978-0-470-11880-1. CANCER DE PULMAO; PROGRAMAS DE APOIO; IMAGENS QUANTITATIVAS; BIOMEDICINA; INSTITUTO NACIONAL DE PADROES E TECNOLOGIA |
| 23721/34351 | US=67 / Imagem Clarke L, Reeves AP, Yankelevitz DF. Evolving imaging resources: public access databases. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 123-30. ISBN 978-0-470-11880-1. EVOLUCAO DOS RECURSOS DE IMAGEM; BASES DE DADOS DE ACESSO PUBLICO |
| 23722/34351 | US=67 / Imagem Baer TM, Mulshine JL. Biomedical imaging archive network. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 131-40. ISBN 978-0-470-11880-1. IMAGEM BIOMEDICA; ARQUIVO DE REDE; BASES DE DADOS; BIOLOGIA MOLECULAR; IMAGEM QUANTITATIVA |
| 23723/34351 | US=67 / Imagem Mulshine JL, Avila RS, Hirsch FR, Yankelevitz DF. Developing CT image-processing tools to accelerate progress in lung cancer drug development. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 141-54. ISBN 978-0-470-11880-1. CANCER DE PULMAO; TOMOGRAFIA COMPUTADORIZADA; DESENVOLVIMENTO DE PROCESSAMENTO DE IMAGEM; FERRAMENTAS; DESENVOLVIMENTO DE DROGAS |
| 23724/34351 | US=69 / Câncer Wheler J, Kurzrock R. Perspectives: bench to bedside and back. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 1-19. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; MEDICINA TRANSLACIONAL; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 23725/34351 | US=69 / Câncer Estey E. Targeted therapy in acute myelogenous leukemia. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 21-42. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; TERAPIA-ALVO NA LEUCEMIA MIELOIDE AGUDA; LEUCEMIA MIELOIDE AGUDA; ATRA E ARSENICO TRIOXIDO OZOGAMICINA; FLT-3 INIBIDORES; INIBIDORES DA FARNESIL TRANSFERASE; EPIGENETICA AGENTES DE ACAO |
| 23726/34351 | US=69 / Câncer Craft BS, Moulder S. Targeted therapy in breast cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 43-59. ISBN 978-1-60327-423-4. TERAPIA-ALVO NO CANCRO DA MAMA; CANCER DE MAMA; TERAPIA BIOLOGICA; TERAPIA-ALVO; TERAPIA ADJUVANTE; DOENCA METASTATICA |